ACN Newswire
Read More

Q&M Group awards 7 dentists with Performance Shares,12-year Service Agreements, and a Private Placement

indie
6 minutes

SINGAPORE, Sep 30, 2022 - (ACN Newswire via SEAPRWire.com) - Mainboard-listed Q&M Dental Group (Singapore) Limited [SGX: QC7] announced on 29 September 2022 the award of 2,014,245 shares to 7 promising next-generation dentists as part of the Q&M Performance Share Plan (PSP) 2018, as well as the proposed placement of an additional 4,985,755 treasury shares, totalling S$1.75 million, through placement to the same dentists.These 7 Key Dentists are the recipients of awards under the PSP 2018 by Q&M in its announcement dated 29 September 2022. These Key Dentists have also expressed their interest to subscribe for further shares as an expression of their confidence in and their commitment to the continued success of the company. They intend to enter into an arrangement similar to that entered into between the founding dentists of the Group in respect of Q&M's controlling shareholder, Quan Min Holdings Pte. Ltd., in order to hold their Shares in Q&M.The placement of 4,985,755 treasury shares at a price of 35.1 Singapore cents is based on the volume weighted average price (VWAP) for trades done on the shares of Q&M on the Singapore Exchange for the full market day o...

ACN Newswire

Restricted Shares Will be Lifted on 22 September, and the Management and Investors of Arrail Group are “Hoarding”, Release High Growth Signals

indie
4 minutes

HONG KONG, Sep 22, 2022 - (ACN Newswire via SEAPRWire.com) - The restricted shares of Arrail Group Limited ("Arrail Group" or the "Company", stock code: 06639.HK), a leading dental services group in China, will be officially lifted and listed for circulation on 22 September 2022. In this regard, the Company's management and investors clearly presented the idea of being "hoarding" and their current confidence.Arrail Group is a leading dental services group and have established a nationwide footprint in China, operating both Arrail Dental, a leading premium dental services brand, and Rytime Dental, a middle-end dental services brand. According to Frost & Sullivan Report, the Company is the largest dental service provider in China's premium private dental service market and the third largest dental service provider in China's entire private dental service market based in terms of total revenue in 2020.Institutional shareholders' confidence in long-term development is demonstrated by "not to reduce its shareholding"Based on the confidence in the industry prospect and the future development of Arrail Group, the major investors of the Company said that they would continue to hold sha...

ACN Newswire
Read More

Q&M Dental net profit, excluding other gains or losses, increased by 25% to S$7.2 million on S$46.8 million of revenue for quarter ended 31 March 2022

indie
6 minutes

SINGAPORE, May 12, 2022 - (ACN Newswire via SEAPRWire.com) - Q&M Dental Group (Singapore) Limited, a leading private dental healthcare group in Asia, reported net profit excluding other gains or losses attributable to shareholders of S$7.2 million for the quarter ended 31 March 2022 (1Q2022) compared to S$5.8 million in the corresponding period (1Q2021).Dr Ng Chin Siau, Chief Executive Officer of Q&M Dental said, "We are heartened by our continuous strong performance in 1Q2022 following a record-setting year FY2021. Our core dental business will remain strong, and with the abolishing of most of the pandemic restrictions, a positive impact on the economy, we are looking forward to resuming our growth trajectory of expanding our network of clinics in the coming quarters."Growth & Expansion in OperationsAs at 31 March 2022, the Group's number of dental outlets in Singapore has grown to 99, from 85 as at 31 March 2021. Similarly in Malaysia, the number of dental outlets has increased to 41, as compared to 36 previously.The Group also continues to focus on its expansion into medical diagnostics, with its associated Company, Aoxin Q&M Dental Group Limited and through its ...

SeaPRwire
Read More

CATALIST-listed AOXIN Q&M records 21% growth in revenue for full year ended 31 December 2021

pandora
8 minutes

– EBITDA grew 47% for 12 months ended 31 Dec 2021– Proposed listing of 49%-owned Acumen Diagnostics on NASDAQ will enhance AOXIN’s shareholder value– Growth trend in revenue expected to continue as COVID-19 situation in China improves SINGAPORE, Feb 23, 2022 – (ACN Newswire) – Catalist listed Aoxin Q&M Dental Limited (“Aoxin” or “the Group”), today announced a 20.8% increase in revenue to RMB160.2 million for full year ended 31 December 2021 (“FY2021”). The Group reported a net loss after tax of RMB7.3 million for FY2021, an improvement from the net loss of RMB12.1 million from a year ago. In 2020, in view of COVID-19 situation, the Chinese government provided temporary relief to businesses by waiving the social security insurance contributions. Aoxin would have additional RMB6.3 million of social security insurance expenses recorded in FY2020 resulting in a Net Loss of RMB18.4 million, instead of RMB12.1 million. Dr. Shao Yongxin, Group Chief Executive Officer of Aoxin Q&M said, “Global economic prospects for 2022 will continue to be uncertain, with many countries still struggling to contain the rapid spread of the Omicron variant. The possibility of new COVID-19 strains c...

SeaPRwire
Read More

Q&M Dental records historic highest-ever revenue and profit after tax for year ended 31 December 2021 and declares a full year dividend yielding 7%

pandora
10 minutes

– Revenue increases by 49% to S$205.6 million and Profit After Tax increases by 98% to S$39.4 million for FY2021– Core dental and medical clinics segment continues strong growth with 27% increase in revenue for FY2021– Declares fourth interim dividend of 1.0 Singapore cent per ordinary share for 4Q2021, giving total dividends of 4.0 Singapore cents per ordinary share for FY2021 and a dividend yield of 7%[1] SINGAPORE, Feb 23, 2022 – (ACN Newswire) – Q&M Dental Group (Singapore) Limited (“Q&M” or together with its subsidiaries, the “Group”), a leading private dental healthcare group in Asia, today reported the highest-ever revenue and profit after tax of S$205.6 million and S$39.4 million respectively for the financial year ended 31 December 2021 (“FY2021”). This is the best set of financials in Q&M’s 25-year history since its founding in 1996. Net profit after tax attributable to shareholders for FY2021 jumped 55% to S$30.5 million compared to S$19.7 million compared to a year ago. Quarterly Financial Performance since the start of Covid-19 (From 4Q2019) The Covid-19 pandemic had no impact on the Group’s core dental and medical clinics business segment and continued its...

ACN Newswire
Read More

EC Healthcare Acquires Multi-Disciplinary Medical Services Centers

indie
4 minutes

HONG KONG, Feb 16, 2022 - (ACN Newswire via SEAPRWire.com) - EC Healthcare (the "Company", which together with its subsidiaries is referred to as the "Group", SEHK stock code: 2138), the largest non-hospital medical group in Hong Kong*, is pleased to announce that the Group enters into a sales and purchase agreement to acquire entire issued share capital of Excellent Power Investments Limited (the "Target Company") for a total consideration of HK$68 million in cash.The Target Company owns Health & Care Dental Services Limited, Health & Care Dental Clinic Limited, Health & Care (Macau) Dental Group Limited, Qualigenics Medical Limited, AmMed Cancer Center (Central) Limited and Humphrey & Partners Medical Services Management Limited and has a long-standing history in providing comprehensive healthcare services in Hong Kong and Macau since 2000. The medical services that the Target Company provide within its 12 clinics including dental services, chronic disease management services, specialty services, imaging and diagnostic services. It also administrates a comprehensive medical network of over 250 affiliated clinics providing general practitioners, specialists and phy...

ACN Newswire
Read More

Acumen Diagnostics granted Ministry of Health COVID-19 offsite PCR testing license, up to 100 sites island-wide

indie
7 minutes

SINGAPORE, Dec 16, 2021 - (ACN Newswire via SEAPRWire.com) - Homegrown medical technology Company, Acumen Diagnostics Pte. Ltd. ("Acumen Diagnostics" or the "Company"), a 51% owned subsidiary of Q&M Dental Group (Singapore) Limited ("Q&M Dental") and 49% owned by Aoxin Q&M Dental Group Limited ("Aoxin Q&M Dental"), today announced that it has been granted a license by the Ministry of Health, Singapore to provide offsite COVID-19 polymerase chain reaction ("PCR") swab services and serology sample collection.The Company will roll out its testing services via Q&M Dental's network of clinics, and also at Acumen Diagnostics' headquarters located at The Gemini, 41 Science Park Road, Singapore.Dr Ong Siew Hwa, Chief Executive Officer & Chief Scientist of Acumen Diagnostics and Executive Director of Aoxin Q&M Dental, said "Vaccination coupled with a robust testing regime remains the best strategy to tackle the virus enabling a safe and more sustainable re-opening of the economy.PCR tests remain the gold standard for accurately detecting COVID-19 cases and with the potential higher transmissibility of new variants such as Omicron, testing needs to be deployed qui...

ACN Newswire
Read More

EC Healthcare Acquires Hong Kong Dental Services Chain

indie
4 minutes

HONG KONG, Nov 30, 2021 - (ACN Newswire via SEAPRWire.com) - EC Healthcare (the "Company", which together with its subsidiaries is referred to as the "Group", SEHK stock code: 2138), the largest non-hospital medical group in Hong Kong*, is pleased to announce that the Group enters into an agreement to acquire 55% of the issued share capital of Bayley & Jackson Dental Surgeons Limited (the "Target Company"), for a total consideration of approximately HK$129 million, which shall be satisfied as to approximately HK$ 119 million in cash and as to approximately HK$10 million by the allotment and issue of Consideration Shares at HK$ 12.557 per share.The Target Company is a dental services chain operator with a long-standing history in Hong Kong providing dental services in Hong Kong since 1958. As of the date of this announcement, the Target Company operates seven dental clinics located in Central, Tsim Sha Tsui, Mong Kok, Repulse Bay and Clean Water Bay of Hong Kong with 32 practicing dentists including dental general practitioners and specialists. According to the unaudited financial information for the year ended 31 March 2021, the profit after tax of the Target Company amounted t...

ACN Newswire
Read More

Q&M Dental net profit surges 154% to S$35.4M for nine months ended 30 September 2021

indie
6 minutes

SINGAPORE, Nov 11, 2021 - (ACN Newswire via SEAPRWire.com) - Q&M Dental Group (Singapore) Limited ("Q&M" or together with its subsidiaries, the "Group"), a leading private dental healthcare group in Asia, today reported net profit after tax attributable to shareholders of S$27.3 million for the nine months ended 30 September 2021 ("9M2021"), and net profit after tax attributable to shareholders S$9.5 million for the three months ended 30 September 2021 ("3Q2021").Quarterly Financial Performance since 4Q2019The Group has grown stronger compared to the pre-Covid-19 period. The Group's revenue rose by 58% from S$36.5 million in 4Q2019 to S$57.7 million in 3Q2021, or 6.78% quarterly compounded growth from 4Q2019 to 3Q2021. Profit before tax grew 112% from S$7.9 million in 4Q2019 to S$16.7 million in 3Q2021, or 11% quarterly compounded growth from 4Q2019 to 3Q2021.Dr Ng Chin Siau, Chief Executive Officer of Q&M added, "The Group's strong financial performance and accomplishments continue to be propelled by our corporate values and philosophy of "Improving Oneself & Unity". We believe that every individual within Q&M strives for continual improvement, and seeks knowle...

ACN Newswire
Read More

Aoxin Q & M acquires 49% stake in Acumen Diagnostics for S$29.4m

indie
8 minutes

SINGAPORE, Oct 4, 2021 - (ACN Newswire via SEAPRWire.com) - Aoxin Q & M Dental Group Ltd (SGX: 1D4.SI) ("Aoxin Q & M") and Q & M Dental Group (Singapore) Limited (SGX: QC7.SI) ("Q & M"), announced today that Aoxin Q & M will acquire 49% of Acumen Diagnostics Pte. Ltd. ("Acumen Diagnostics") for a consideration of S$29.4 million. Acumen Diagnostics has a preliminary valuation of S$60 million.Diagram 1: Shareholdings upon completion of acquisition of Acumen Diagnostics by Aoxin Q & MAcquisition & ValuationAoxin Q & M has entered into a conditional sale and purchase deed with Acumen Diagnostics' shareholders, Dr Ong Siew Hwa and Acumen Holdings Pte. Ltd., to acquire their 49% shareholding in Acumen Diagnostics.The preliminary valuation of Acumen Diagnostics (upon completion of a restructuring exercise involving Acumen Research Laboratories Pte. Ltd.) is S$60 million, derived based on the latest financial statements of Acumen Diagnostics, taking into account the earnings and growth prospects of its business.The purchase consideration for the shares is S$29.4 million, to be satisfied by way of the allotment and issuance of new ordinary shares in the capit...

SeaPRwire

Dentist struck off S’pore dental register for making false Chas claims

aseanpr
2 minutes

SINGAPORE - Dentist Teo Eu Gene, who was jailed last year for having submitted false claims for dental procedures, has been struck off the official dental register. He will not be permitted to practise as a dentist in Singapore for at least three years. After this period, he can apply for his name to be restored in the register, said the Singapore Dental Council in a statement on Friday (June 25). Last year, Teo became the first person to be jailed for cheating the Government through the Community Health Assist Scheme (Chas). He was sentenced to 46 weeks' jail after being convicted of 25 charges of making false Chas claims. These claims were for dental procedures between 2014 and 2015. Teo's actions caused two polyclinic groups - SingHealth Polyclinics and National Healthcare Group Polyclinics - that process and reimburse Chas claims on behalf of the Ministry of Health to wrongfully disburse more than $18,000. On Friday, the Singapore Dental Council said it held on April 12 a disciplinary inquiry against Teo, who previously practised at Phoenix Dental Surgery clinics. The disciplinary committee noted that Teo's dishonest conduct and convictions seriously impinged upon the reputatio...